Differential expression of connective tissue growth factor in inflammatory bowel disease - PubMed (original) (raw)
Comparative Study
doi: 10.1159/000079845. Epub 2004 Jul 14.
Affiliations
- PMID: 15256831
- DOI: 10.1159/000079845
Comparative Study
Differential expression of connective tissue growth factor in inflammatory bowel disease
Fabio F di Mola et al. Digestion. 2004.
Abstract
Inflammatory bowel disease consists of Crohn's disease (CD) and ulcerative colitis (UC). A major clinical problem in some patients is to differentiate clearly between these entities, which is important when planning appropriate medical and surgical treatment. Connective tissue growth factor (CTGF), a novel peptide involved in fibrotic disorders, was analyzed in the present study in CD and UC patients to evaluate its possible role in these two disorders. Twenty-five normal human intestinal tissue samples were obtained through an organ donor program. CD tissues were obtained from 28 individuals undergoing partial intestinal resection (17 small bowel; 11 large bowel) due to complications of the disease. UC tissue samples were obtained from 16 patients undergoing colectomy due to complications of the disease. Expression of CTGF was studied by Northern blot analysis. In situ hybridization was used to localize mRNA moieties in the tissue samples. Northern blot analysis revealed an average 5-fold increase in CTGF mRNA expression in 89% (25/28) of CD tissue samples by comparison with normal controls (p < 0.0001). In contrast, in UC samples CTGF mRNA levels were comparable to those of normal controls. However, UC tissue samples exhibited enhanced TGF-beta1 mRNA levels (4-fold; p < 0.05). In situ hybridization in CD samples showed CTGF mRNA localized especially in fibroblasts within the submucosal layer, around lymph follicles and in some areas of intense damage in the proximity of the luminal surface, whereas inflammatory cells were devoid of any CTGF mRNA signal. The present data indicate that CTGF plays a different role in IBD and might be useful, especially in those cases with unusual disease presentation, to better differentiate UC and CD. In addition, our data indicate a crucial role for CTGF in CD, where fibrosis and stenosis are frequent complications that require surgery.
Similar articles
- Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis.
di Mola FF, Friess H, Riesle E, Koliopanos A, Büchler P, Zhu Z, Brigstock DR, Korc M, Büchler MW. di Mola FF, et al. Ann Surg. 2002 Jan;235(1):60-7. doi: 10.1097/00000658-200201000-00008. Ann Surg. 2002. PMID: 11753043 Free PMC article. - Transforming growth factor-beta pathway is activated in cholecystolithiasis.
Köninger J, di Mola FF, Di Sebastiano P, Gardini A, Brigstock DR, Innocenti P, Büchler MW, Friess H. Köninger J, et al. Langenbecks Arch Surg. 2005 Feb;390(1):21-8. doi: 10.1007/s00423-004-0517-4. Epub 2004 Nov 20. Langenbecks Arch Surg. 2005. PMID: 15702358 - Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis.
di Mola FF, Friess H, Martignoni ME, Di Sebastiano P, Zimmermann A, Innocenti P, Graber H, Gold LI, Korc M, Büchler MW. di Mola FF, et al. Ann Surg. 1999 Jul;230(1):63-71. doi: 10.1097/00000658-199907000-00010. Ann Surg. 1999. PMID: 10400038 Free PMC article. - Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Colitis Foundation of America; Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, et al. J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3. J Pediatr Gastroenterol Nutr. 2007. PMID: 17460505 - Indeterminate colitis.
Geboes K, De Hertogh G. Geboes K, et al. Inflamm Bowel Dis. 2003 Sep;9(5):324-31. doi: 10.1097/00054725-200309000-00007. Inflamm Bowel Dis. 2003. PMID: 14555917 Review.
Cited by
- Mechanical stress-induced connective tissue growth factor plays a critical role in intestinal fibrosis in Crohn's-like colitis.
Lin YM, Zhang K, Geesala R, Lipson KE, Qiu S, Powell DW, Cohn S, Shi XZ. Lin YM, et al. Am J Physiol Gastrointest Liver Physiol. 2024 Aug 1;327(2):G295-G305. doi: 10.1152/ajpgi.00123.2024. Epub 2024 Jul 2. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 38954823 - Serum level of full-length connective tissue growth factor reflects liver fibrosis stage in patients with Fontan-associated liver disease.
Kogiso T, Takayanagi K, Ishizuka T, Otsuka M, Inai K, Ogasawara Y, Horiuchi K, Taniai M, Tokushige K. Kogiso T, et al. PLoS One. 2024 Jan 2;19(1):e0296375. doi: 10.1371/journal.pone.0296375. eCollection 2024. PLoS One. 2024. PMID: 38166061 Free PMC article. - The rs9402373 polymorphism of CTGF gene may not be related to inflammatory bowel disease susceptibility in Chinese population based on ARMS-PCR genotyping.
Xie Y, Ping Y, Yu P, Liu W, Chen X, Wang Q, Chen Y, Duan X, Wang X. Xie Y, et al. Heliyon. 2023 Jun 5;9(6):e17003. doi: 10.1016/j.heliyon.2023.e17003. eCollection 2023 Jun. Heliyon. 2023. PMID: 37484218 Free PMC article. - Targeting Mechano-Transcription Process as Therapeutic Intervention in Gastrointestinal Disorders.
Geesala R, Lin YM, Zhang K, Shi XZ. Geesala R, et al. Front Pharmacol. 2021 Dec 21;12:809350. doi: 10.3389/fphar.2021.809350. eCollection 2021. Front Pharmacol. 2021. PMID: 34992543 Free PMC article. Review. - Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.
Lin SN, Mao R, Qian C, Bettenworth D, Wang J, Li J, Bruining DH, Jairath V, Feagan BG, Chen MH; Stenosis Therapy and Antifibrotic Research (STAR) Consortium; Rieder F. Lin SN, et al. Physiol Rev. 2022 Apr 1;102(2):605-652. doi: 10.1152/physrev.00005.2021. Epub 2021 Sep 27. Physiol Rev. 2022. PMID: 34569264 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous